Sequana Medical N.V (2SE) Stock Statistics & Valuation Metrics

Sequana Medical N.V has a market cap or net worth of €47.76M. The enterprise value is €114.92M.

Sequana Medical N.V has 78,172,035 shares outstanding. The number of shares has decreased by -2.65% in one year.

Sequana Medical N.V’s return on equity (ROE) is 1.01 and return on invested capital (ROIC) is 540.85%.

The current PE Ratio of Sequana Medical N.V is ―. Sequana Medical N.V’s PEG ratio is ―.

In the last 12 months, Sequana Medical N.V had revenue of 106.00K and earned -44.65M in profits. Earnings per share was -1.22.

In the last 12 months, operating cash flow was -17.81M and capital expenditures -66.09K, giving a free cash flow of -17.88M billion.

Sequana Medical N.V pays an annual dividend of ―, resulting in a dividend yield of ―

Sequana Medical N.V upcoming earnings date is Aug 27, 2026, TBA (Not Confirmed).

Sequana Medical N.V as a current ratio of 0.12, with Debt / Equity ratio of -105.68%

In the past 12 months, Sequana Medical N.V has paid 280.00K in taxes.

Sequana Medical N.V EV to EBITDA ratio is -8.53, with an EV/FCF ratio of -7.23.

Sequana Medical N.V has €7.31M in cash and marketable securities with €40.11M in debt, giving a net cash position of -€34.09M billion.

Gross margin is 0.00%, with operating margin of -17647.17%, and net profit margin of -42126.42%.

The average price target for Sequana Medical N.V is ―, which is 11.43% higher than the current price. The consensus rating is ―